dr. aubrey de grey - changing priorities in rejuvenation technologies - lifespan.io
Published 3 years ago • 14K plays • Length 28:23Download video MP4
Download video MP3
Similar videos
-
29:29
aubrey de grey | rejuvenation framework
-
42:22
aubrey de grey | eard2020 keynote speech: maximizing the pace of biomedical gerontology
-
2:45
aubrey de grey explains sens anti-cancer strategy and lifespan.io campaign at d.n.a. conference
-
11:55
dr. aubrey de grey interview : controlling the main aging damages - where are we now? | leaf
-
0:43
aubrey de grey: humans could reach extreme longevity in 20 years #longevity #lifeextension #lifespan
-
27:19
dr. aubrey de grey at ending age-related diseases 2018 — rejuvenation is finally an industry | leaf
-
1:08
drs. aubrey de grey, alexandra stolzing: what is the optimal anti-aging diet? | leaf panel
-
50:37
unlocking the secrets to reversing age and living longer – interview aubrey de grey
-
1:06:27
stopping the aging clock w. aubrey de grey. can future longevity tech reverse aging and cure cancer?
-
31:24
age reversal blueprint - dr. aubrey de grey interviews bryan johnson
-
2:16
aubrey de grey: the importance of physical biomarkers for aging | leaf panel
-
7:38
aubrey de grey talks sens & challenges to longevity at eard 2021
-
1:53:10
leaf panel: how to promote longevity? ft. drs. aubrey de grey, alexandra stolzing, oliver medvedik
-
2:08
sens research foundation — mitosens mitochondrial repair project | lifespan.io crowdfunding campaign
-
16:04
do you really want to live forever — what is the real aim of life extension advocacy? | leaf panel
-
34:59
eard 2023 panel discussion: is aging truly reversible?
-
28:40
will his ‘rejuvenation alternative’ beat ageing? | dr aubrey de grey (sens foundation)
-
19:15
rejuvenation roundup july 2021
-
7:57
is aging a disease? david sinclair & aubrey de grey who reaction
-
49:08
dr. aubrey de grey: "rejuvenation biotechnology"
-
4:43
aubrey de grey: why doesn't the government fund longevity research? | leaf panel
-
21:57
aubrey de grey - can covid-19 improve the medical incentives to develop longevity therapies?